Cubist Systematic Strategies’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-73,482
Closed -$1.35M 4258
2024
Q1
$1.35M Sell
73,482
-212,408
-74% -$3.37M 0.01% 1929
2023
Q4
$3.51M Sell
285,890
-93,420
-25% -$876K 0.02% 1089
2023
Q3
$5.69M Buy
379,310
+224,709
+145% +$4.68M 0.04% 675
2023
Q2
$5.02M Sell
154,601
-180,256
-54% -$6.58M 0.03% 845
2023
Q1
$13.1M Buy
334,857
+123,428
+58% +$6.04M 0.08% 324
2022
Q4
$11.2M Buy
211,429
+146,692
+227% +$7.14M 0.07% 419
2022
Q3
$2.91M Buy
64,737
+43,192
+200% +$1.86M 0.02% 1620
2022
Q2
$784K Buy
21,545
+11,845
+122% +$430K ﹤0.01% 2675
2022
Q1
$401K Buy
+9,700
New +$341K ﹤0.01% 2672
2021
Q4
Sell
-12,637
Closed -$695K 3684
2021
Q3
$695K Buy
+12,637
New +$661K 0.01% 1804
2021
Q2
Sell
-7,490
Closed -$379K 3145
2021
Q1
$379K Sell
7,490
-14,393
-66% -$800K ﹤0.01% 2115
2020
Q4
$1.38M Sell
21,883
-4,132
-16% -$256K 0.02% 1172
2020
Q3
$1.75M Buy
26,015
+14,115
+119% +$770K 0.03% 988
2020
Q2
$498K Buy
+11,900
New +$457K 0.01% 1594
2020
Q1
Sell
-7,265
Closed -$293K 2529
2019
Q4
$293K Buy
+7,265
New +$254K 0.01% 1848
2019
Q3
Sell
-18,637
Closed -$903K 2545
2019
Q2
$903K Buy
+18,637
New +$793K 0.02% 1107

Other funds holding SILK

Cubist Systematic Strategies's SILK Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2024, closing a stake of 73,482 shares — an estimated $1.35M sold.

Cubist Systematic Strategies first reported a position in SILK in Q2 2019 and held it in 16 quarters. The position peaked at $13.1M in Q1 2023. 172 funds tracked by Wall St. Rank hold SILK as of Q2 2024.

  • Cubist Systematic Strategies reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 73,482 Silk Road Medical, Inc. Common Stock shares in Q2 2024, an estimated $1.35M.
  • Cubist Systematic Strategies first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 16 quarters.
  • Cubist Systematic Strategies's Silk Road Medical, Inc. Common Stock position peaked at $13.1M in Q1 2023.
  • 172 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.